Invest in

Battling Cancer


Declaring war on cancer

Cancer is a leading cause of death worldwide with new cases expected to rise on the back of an aging population. Researchers also attribute the rising prevalence of cancer to shifts in lifestyle and diets spurred by growing wealth in rapidly growing economies. China is a prime example of this trend where lung cancer is the leading cause of death. Meanwhile, cancer medicine sales continue to rise along with the number of approved cancer therapies, the latter due in part to more streamlined FDA approval processes. Together, these key trends add up to significant opportunities in the pharmaceutical and biotech sectors. <br><br><b>Battling Cancer in numbers:</b> </br>-18 million cancer cases globally estimated[1] with the number of new cancer cases expected to rise to 23.6 million by 2030.[2] </br>-The FDA approved a record number of novel drugs in 2018. </br>-Cancer drugs are approved fastest across all therapeutic areas in the U.S., averaging about 1.1 years from filing to approval.[3] </br>-Global spending on cancer drugs continues to rise estimated at $133 billion globally in 2017, up from $96 billion in 2013.[4] </br>-List prices of new cancer medicine have grown over the past decade, with the median annual cost of a new cancer drug launched in 2017 topping $150,000, compared to $79,000 for the new cancer drugs launched in 2013.[5] See More
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for as low as $9.95.
Join over 100,000 Motif customers customizing, building, and sharing motifs.
Portfolio Index 1 YR Return
Open a Motif account to view and trade this thematic portfolio
Weight Segment & Stocks Symbol 1 YR Return
40.6% Large Pharma 5.3%
21.0% Bristol-Myers Squibb Company BMY 15.0%
19.6% Novartis AG NVS 5.0%
34.8% Biotech 1.8%
19.4% Amgen Inc. AMGN 0.8%
5.1% 8xxxxxx 8xxxxxxx 8xxx 8xxx 88.8%
2.7% 8xxxxxx 8xxx 8xxx 88.8%
1.3% 8xxxxxxxx 8xxx 8xxx 88.8%
1.3% 8xxxxxx 8xxx 8xxx --
1.1% 8xxxxxxxx 8xxx 8xxx 88.8%
1.0% 8xxxxxxx 8xxx 8xxx 88.8%
1.0% 8xxxxxx 8xxx 8xxx --
1.0% 8xxxxxxxxx 8xxx 8xxx 88.8%
0.9% 8xxxxx 8x 8xxx 88.8%
12.8% Medical Equipment 2.8%
11.7% 8xxxxx 8xxxxxx 8xxxxxx 8xxx 8xx 88.8%
1.1% 8xxxxxx 8xxxxxxxxxxx 8xxx 88.8%
8.6% Life Science Equipment 14.7%
4.5% 8xxxx 8xxxxxxx 8xxxxxxxxxx 8xxx 88.8%
3.0% 8xxxxxxx 8xxxxx 8xxx 8x --
1.2% 8xxxxx 8xxxxxxx 8xxx 8xxx 88.8%
3.2% Specialty Pharma 18.8%
1.1% 8xxxxxxxx 8xxxxxxxxxx 8xx 8xxx --
1.1% 8xxxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
1.0% 8xxxxxxxx 8xxxxxxx 8xxx 8xxx --
Quotes delayed 15 mins. Currently Sep 20, 2019 7:17:54 PM. Fields are marked with -- when data is unavailable.